Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Cash & Current Investments (2020 - 2025)

Historic Cash & Current Investments for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $42.2 million.

  • Bioventus' Cash & Current Investments fell 211.26% to $42.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.2 million, marking a year-over-year decrease of 211.26%. This contributed to the annual value of $41.6 million for FY2024, which is 1249.32% up from last year.
  • Latest data reveals that Bioventus reported Cash & Current Investments of $42.2 million as of Q3 2025, which was down 211.26% from $32.9 million recorded in Q2 2025.
  • In the past 5 years, Bioventus' Cash & Current Investments ranged from a high of $140.1 million in Q3 2021 and a low of $22.8 million during Q1 2025
  • In the last 5 years, Bioventus' Cash & Current Investments had a median value of $37.0 million in 2023 and averaged $51.2 million.
  • In the last 5 years, Bioventus' Cash & Current Investments soared by 8063.0% in 2021 and then plummeted by 7575.1% in 2022.
  • Over the past 5 years, Bioventus' Cash & Current Investments (Quarter) stood at $49.2 million in 2021, then crashed by 38.62% to $30.2 million in 2022, then grew by 22.36% to $37.0 million in 2023, then grew by 12.49% to $41.6 million in 2024, then increased by 1.4% to $42.2 million in 2025.
  • Its Cash & Current Investments stands at $42.2 million for Q3 2025, versus $32.9 million for Q2 2025 and $22.8 million for Q1 2025.